Both measurements did not provide evidence for a significant increase of apoptosis under the combinatorial treatment compared to single treatments showing a remarkable difference to both ovarian cancer cell lines with CCNE1-amplification (OVCAR-3, COV318). Here, CCNE1 is linked to ovarian carcinoma.